Publications by authors named "Jing 'Daisy' Zhu"
Pharmacogenomics
February 2022
Article Synopsis
- - The study assessed how preemptive multigene pharmacogenomic (PGx) testing could affect medication prescriptions in patients undergoing percutaneous coronary intervention (PCI) and allogeneic hematopoietic cell transplant (allo-HCT).
- - It was found that a significant percentage of PCI (66.5%) and allo-HCT (90.1%) patients were prescribed at least one medication with actionable PGx recommendations.
- - Simulations indicated that implementing multigene PGx testing could create numerous opportunities for personalized medication choices, potentially improving treatment beyond just standard drugs like clopidogrel and tacrolimus.
